Skip to main content
FDA OKs phenylketonuria therapy
10/12/2018

The FDA has approved Palynziq, or pegvaliase, as a treatment for adults with phenylketonuria. "Pegvaliase is very effective in metabolizing phenylalanine, making it possible for most patients who respond to the medication to consume a normal amount of food protein," study author Barbara Burton said.

Full Story: